Neurodegeneration with Brain Iron Accumulation

Area of Science:

• Neuroscience
• Genetics
• Neurology

Background:

• Iron is vital for neural development but can be neurotoxic if dysregulated.
• Hereditary conditions can disrupt iron homeostasis, leading to pathological iron deposition in the CNS.
• Neurodegeneration with brain iron accumulation (NBIA) encompasses disorders characterized by excessive brain iron.

Purpose of the Study:

• To review ten distinct NBIA disorders.
• To emphasize clinical presentations and neuroimaging findings.
• To discuss differential diagnosis and iron chelation therapy.

Main Methods:

• Review of ten NBIA disorders including pantothenate kinase 2-associated neurodegeneration (PKAN), neuroferritinopathy, aceruloplasminemia, Kufor-Rakeb disease (KRD), PLA2G6-associated neurodegeneration (PLAN), FA2H-associated neurodegeneration (FAHN), Woodhouse-Sakati syndrome (WSS), beta-propeller protein-associated neurodegeneration (BPAN), mitochondrial membrane protein-associated neurodegeneration (MPAN), and coenzyme A synthase protein-associated neurodegeneration (CoPAN).
• Focus on clinical syndromes and neuroimaging, particularly iron-sensitive magnetic resonance scanning sequences.
• Exploration of diagnostic approaches and current therapeutic strategies, including iron chelation.

Main Results:

• Detailed descriptions of ten NBIA disorders are provided.
• Neuroimaging, especially MRI, is crucial for identifying pathological iron accumulation.
• Clinical heterogeneity exists across the spectrum of NBIA conditions.

Conclusions:

• NBIA disorders represent a group of complex neurodegenerative conditions linked to iron dysregulation.
• Accurate diagnosis relies on integrating clinical, genetic, and neuroimaging data.
• Therapeutic interventions, including iron chelation, are being investigated for specific NBIA entities.